Immunoprecipitation of whole-cell lysates with an antiserum against SMYD3 or RPB1, followed by immunoblotting, revealed that SMYD3 is a molecular partner of RPB1 in CRC and GC cells (Figs. 3E, 4, and Appendix Fig. S2). The gene discussed is POLR2A; the disease is gastric cancer.